We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Clavis Pharma ASA Receives $1.1 Million Grant from Innovation Norway

News   Aug 28, 2009

 
Clavis Pharma ASA Receives $1.1 Million Grant from Innovation Norway
 
 
 

RELATED ARTICLES

p38 Protein Regulates Angiogenesis in Colon Cancer

News

Inhibition of the protein "p38" boosts the formation of blood vessels in human and mice colon cancers, according to a study published in Nature Communications. Known as angiogenesis, this process is critical in fueling cancer cells, allowing them to grow and to eventually develop metastases.

READ MORE

“Semi-synthetic” Bacteria Churn Out Proteins Containing Unnatural Amino Acids

News

Researchers have optimized a semi-synthetic bacteria to efficiently produce proteins containing unnatural amino acids.

READ MORE

Diving Deeper Into the Metabolism of the Autistic Brain

News

Scientists looked into the differences in the concentrations of multiple metabolites in healthy humans and individuals suffering from Autism Spectrum Disorder (ASD), gaining a deeper insight into the molecular processes that take place in the brain of autistic individuals.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE